Home > Research > Publications & Outputs > Optimizing Village-Level Targeting of Active Ca...

Links

Text available via DOI:

View graph of relations

Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India. / Bindroo, Joy; Priyamvada, Khushbu; Chapman, Lloyd A.C. et al.
In: Frontiers in cellular and infection microbiology, Vol. 11, 648847, 24.03.2021.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Bindroo, J, Priyamvada, K, Chapman, LAC, Mahapatra, T, Sinha, B, Banerjee, I, Mishra, PK, Rooj, B, Kundan, K, Roy, N, Gill, NK, Hightower, A, Sharma, MP, Dhingra, N, Bern, C & Srikantiah, S 2021, 'Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India', Frontiers in cellular and infection microbiology, vol. 11, 648847. https://doi.org/10.3389/fcimb.2021.648847

APA

Bindroo, J., Priyamvada, K., Chapman, L. A. C., Mahapatra, T., Sinha, B., Banerjee, I., Mishra, P. K., Rooj, B., Kundan, K., Roy, N., Gill, N. K., Hightower, A., Sharma, M. P., Dhingra, N., Bern, C., & Srikantiah, S. (2021). Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India. Frontiers in cellular and infection microbiology, 11, Article 648847. https://doi.org/10.3389/fcimb.2021.648847

Vancouver

Bindroo J, Priyamvada K, Chapman LAC, Mahapatra T, Sinha B, Banerjee I et al. Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India. Frontiers in cellular and infection microbiology. 2021 Mar 24;11:648847. doi: 10.3389/fcimb.2021.648847

Author

Bindroo, Joy ; Priyamvada, Khushbu ; Chapman, Lloyd A.C. et al. / Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India. In: Frontiers in cellular and infection microbiology. 2021 ; Vol. 11.

Bibtex

@article{338ffad9fe5c43618fe2ba5d7b11cf6a,
title = "Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India",
abstract = "Background: India has made major progress in improving control of visceral leishmaniasis (VL) in recent years, in part through shortening the time infectious patients remain untreated. Active case detection decreases the time from VL onset to diagnosis and treatment, but requires substantial human resources. Targeting approaches are therefore essential to feasibility. Methods: We analyzed data from the Kala-azar Management Information System (KAMIS), using village-level VL cases over specific time intervals to predict risk in subsequent years. We also graphed the time between cases in villages and examined how these patterns track with village-level risk of additional cases across the range of cumulative village case-loads. Finally, we assessed the trade-off between ACD effort and yield. Results: In 2013, only 9.3% of all villages reported VL cases; this proportion shrank to 3.9% in 2019. Newly affected villages as a percentage of all affected villages decreased from 54.3% in 2014 to 23.5% in 2019, as more surveillance data accumulated and overall VL incidence declined. The risk of additional cases in a village increased with increasing cumulative incidence, reaching approximately 90% in villages with 12 cases and 100% in villages with 45 cases, but the vast majority of villages had small cumulative case numbers. The time-to-next-case decreased with increasing case-load. Using a 3-year window (2016–2018), a threshold of seven VL cases at the village level selects 329 villages and yields 23% of cases reported in 2019, while a threshold of three cases selects 1,241 villages and yields 46% of cases reported in 2019. Using a 6-year window increases both effort and yield. Conclusion: Decisions on targeting must consider the trade-off between number of villages targeted and yield and will depend upon the operational efficiencies of existing programs and the feasibility of specific ACD approaches. The maintenance of a sensitive, comprehensive VL surveillance system will be crucial to preventing future VL resurgence.",
keywords = "disease control, epidemiology, India, surveillance, visceral leishmaniasis",
author = "Joy Bindroo and Khushbu Priyamvada and Chapman, {Lloyd A.C.} and Tanmay Mahapatra and Bikas Sinha and Indranath Banerjee and Mishra, {Prabhas Kumar} and Basab Rooj and Kumar Kundan and Nupur Roy and Gill, {Naresh Kumar} and Allen Hightower and Sharma, {Madan Prasad} and Neeraj Dhingra and Caryn Bern and Sridhar Srikantiah",
note = "Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2021 Bindroo, Priyamvada, Chapman, Mahapatra, Sinha, Banerjee, Mishra, Rooj, Kundan, Roy, Gill, Hightower, Sharma, Dhingra, Bern and Srikantiah.",
year = "2021",
month = mar,
day = "24",
doi = "10.3389/fcimb.2021.648847",
language = "English",
volume = "11",
journal = "Frontiers in cellular and infection microbiology",
issn = "2235-2988",
publisher = "NLM (Medline)",

}

RIS

TY - JOUR

T1 - Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India

AU - Bindroo, Joy

AU - Priyamvada, Khushbu

AU - Chapman, Lloyd A.C.

AU - Mahapatra, Tanmay

AU - Sinha, Bikas

AU - Banerjee, Indranath

AU - Mishra, Prabhas Kumar

AU - Rooj, Basab

AU - Kundan, Kumar

AU - Roy, Nupur

AU - Gill, Naresh Kumar

AU - Hightower, Allen

AU - Sharma, Madan Prasad

AU - Dhingra, Neeraj

AU - Bern, Caryn

AU - Srikantiah, Sridhar

N1 - Publisher Copyright: © Copyright © 2021 Bindroo, Priyamvada, Chapman, Mahapatra, Sinha, Banerjee, Mishra, Rooj, Kundan, Roy, Gill, Hightower, Sharma, Dhingra, Bern and Srikantiah.

PY - 2021/3/24

Y1 - 2021/3/24

N2 - Background: India has made major progress in improving control of visceral leishmaniasis (VL) in recent years, in part through shortening the time infectious patients remain untreated. Active case detection decreases the time from VL onset to diagnosis and treatment, but requires substantial human resources. Targeting approaches are therefore essential to feasibility. Methods: We analyzed data from the Kala-azar Management Information System (KAMIS), using village-level VL cases over specific time intervals to predict risk in subsequent years. We also graphed the time between cases in villages and examined how these patterns track with village-level risk of additional cases across the range of cumulative village case-loads. Finally, we assessed the trade-off between ACD effort and yield. Results: In 2013, only 9.3% of all villages reported VL cases; this proportion shrank to 3.9% in 2019. Newly affected villages as a percentage of all affected villages decreased from 54.3% in 2014 to 23.5% in 2019, as more surveillance data accumulated and overall VL incidence declined. The risk of additional cases in a village increased with increasing cumulative incidence, reaching approximately 90% in villages with 12 cases and 100% in villages with 45 cases, but the vast majority of villages had small cumulative case numbers. The time-to-next-case decreased with increasing case-load. Using a 3-year window (2016–2018), a threshold of seven VL cases at the village level selects 329 villages and yields 23% of cases reported in 2019, while a threshold of three cases selects 1,241 villages and yields 46% of cases reported in 2019. Using a 6-year window increases both effort and yield. Conclusion: Decisions on targeting must consider the trade-off between number of villages targeted and yield and will depend upon the operational efficiencies of existing programs and the feasibility of specific ACD approaches. The maintenance of a sensitive, comprehensive VL surveillance system will be crucial to preventing future VL resurgence.

AB - Background: India has made major progress in improving control of visceral leishmaniasis (VL) in recent years, in part through shortening the time infectious patients remain untreated. Active case detection decreases the time from VL onset to diagnosis and treatment, but requires substantial human resources. Targeting approaches are therefore essential to feasibility. Methods: We analyzed data from the Kala-azar Management Information System (KAMIS), using village-level VL cases over specific time intervals to predict risk in subsequent years. We also graphed the time between cases in villages and examined how these patterns track with village-level risk of additional cases across the range of cumulative village case-loads. Finally, we assessed the trade-off between ACD effort and yield. Results: In 2013, only 9.3% of all villages reported VL cases; this proportion shrank to 3.9% in 2019. Newly affected villages as a percentage of all affected villages decreased from 54.3% in 2014 to 23.5% in 2019, as more surveillance data accumulated and overall VL incidence declined. The risk of additional cases in a village increased with increasing cumulative incidence, reaching approximately 90% in villages with 12 cases and 100% in villages with 45 cases, but the vast majority of villages had small cumulative case numbers. The time-to-next-case decreased with increasing case-load. Using a 3-year window (2016–2018), a threshold of seven VL cases at the village level selects 329 villages and yields 23% of cases reported in 2019, while a threshold of three cases selects 1,241 villages and yields 46% of cases reported in 2019. Using a 6-year window increases both effort and yield. Conclusion: Decisions on targeting must consider the trade-off between number of villages targeted and yield and will depend upon the operational efficiencies of existing programs and the feasibility of specific ACD approaches. The maintenance of a sensitive, comprehensive VL surveillance system will be crucial to preventing future VL resurgence.

KW - disease control

KW - epidemiology

KW - India

KW - surveillance

KW - visceral leishmaniasis

U2 - 10.3389/fcimb.2021.648847

DO - 10.3389/fcimb.2021.648847

M3 - Journal article

C2 - 33842395

AN - SCOPUS:85103773540

VL - 11

JO - Frontiers in cellular and infection microbiology

JF - Frontiers in cellular and infection microbiology

SN - 2235-2988

M1 - 648847

ER -